Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
FDA+ channel feed
Checkpoint wins FDA approval of checkpoint inhibitor in advanced skin cancer, seeks partner for launch
5 months ago
Pharma
Organon's steroid-free cream Vtama wins approval in atopic dermatitis
5 months ago
Pharma
FDA stands by mifepristone safety label in federal court challenge
5 months ago
Pharma
Law
EMA's committee says expanded label for Lilly's Mounjaro into sleep apnea not necessary
5 months ago
Pharma
Safety concerns and trial holds for pediatric RSV vaccines prompt caution from FDA adcomm
5 months ago
R&D
Pharma
'Serious liver injury' cases lead FDA to call for monitoring of Ocaliva patients
5 months ago
Pharma
During Covid, RFK Jr. lobbied against vaccine EUAs for children. As HHS secretary, he could rescind them
5 months ago
Pharma
Coronavirus
Drugs are approved — and made available — faster in US than most of EU, data show
5 months ago
Pharma
Marketing
The Endpoints 100: The biotech industry braces for Trump 2.0
5 months ago
Deals
Bioregnum
UniQure stock doubles on FDA 'alignment' over accelerated approval for Huntington's drug
5 months ago
Pharma
Cases of severe RSV in two Moderna vaccine candidates' trials raise questions about future
5 months ago
R&D
Supreme Court declines to take PhRMA-Arkansas 340B case
5 months ago
Pharma
Law
Agios' stock drops after disclosing new liver-related safety warning in filing to FDA
5 months ago
Pharma
Biosecure bill is left out of end-of-year defense package, dealing blow to chances
5 months ago
China
Manufacturing
European Commission greenlights $16.5B Novo-Catalent acquisition
5 months ago
Deals
Manufacturing
Merus receives FDA accelerated approval to treat NRG1+ cancers
5 months ago
Pharma
USPTO withdraws proposed patent rule criticized by pharma industry
5 months ago
Pharma
FDA spells out new expedited withdrawal procedures for accelerated approvals
5 months ago
Pharma
Imfinzi snags another FDA nod to treat lung cancer, this time for limited-stage SCLC
5 months ago
Pharma
Biosecure compromise could add executive review process for named companies, sources say
5 months ago
R&D
Manufacturing
Moderna CEO defends pandemic prep efforts with critics set to enter Trump’s administration
5 months ago
R&D
Pharma
Trade group tells FDA that semaglutide is not too 'complex' for compounding
5 months ago
Pharma
Bluebird and Vertex's sickle cell gene therapies to kick off new Medicaid access model
5 months ago
Pharma
Lilly drops body mass ranges from FDA label for weight loss drug
5 months ago
Pharma
First page
Previous page
9
10
11
12
13
14
15
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit